The study showed the validity of quantification of hunger, satiety, and prospective food consumption measured by VAS as well as measurement of ad libitum energy consumption and showed that the appetite recordings during the breakfast meal predicted the energy intake during the lunch meal [3]
A healthcare professional can assess whether dose adjustment of the medication is appropriate, review concurrent medications that may contribute to constipation, and exclude other underlying causes
Detailed analytical documentation accompanies every shipment, allowing laboratories to trace each batch back to its manufacturing run
Starting low gives central receptors time to downregulate before exposure climbs [6][1]
Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide
The first GLP-1 receptor agonist, exenatide, was developed in 2005 and safely prescribed ever since